Arbor Trust Wealth Advisors, LLC Biogen Inc. Transaction History

Arbor Trust Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$236.26 - $355.63 $172,469 - $259,609	-730 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$264.77 - $305.71 $193,282 - $223,168	730 New	730 $207,000
Q2 2020 Aug 05, 2020	SELL	$258.66 - $342.55 $209,514 - $277,465	-810 Closed	0 $0
Q4 2019 Feb 03, 2020	BUY	$220.06 - $304.07 $178,248 - $246,296	810 New	810 $240,000

1,050

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $27.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Arbor Trust Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Arbor Trust Wealth Advisors, LLC with notifications on news.